Training and Performance of an Electrocardiogram-Enabled Machine Learning Model for Detection of Advanced Chronic Liver Disease
Authors:
- Puru RattanPRPuru Rattan
- Joseph C. AhnJAJoseph C. Ahn
- Beatriz Sordi CharaBCBeatriz Sordi Chara
- Aidan F. MullanAMAidan F. Mullan
- Kan LiuKLKan Liu
- Zachi I. AttiaZAZachi I. Attia
- Alina AllenAAAlina Allen
- Vijay H. ShahVSVijay H. Shah
- Patrick S. KamathPKPatrick S. Kamath
- Peter A. NoseworthyPNPeter A. Noseworthy
- Douglas A. SimonettoDSDouglas A. Simonetto
- 27 March 2025
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (10) , 2452-2456
Abstract
INTRODUCTION: Building on prior results, we hypothesized that an electrocardiogram (ECG)-enabled machine learning (ML) model could be used to detect advanced chronic liver disease (CLD). METHODS: A cohort with CLD and 12-lead ECGs was matched with controls from electronic health records. A ML model was trained as a binary classifier. RESULTS: There are 12,930 patients with CLD and 64,577 controls in the cohort. The model's discriminative ability to classify CLD showed an area under the receiver-operating characteristic curve 0.858 (95% confidence interval: 0.850–0.866), and at the chosen threshold, CLD ECGs had 12 times higher odds of being classified as CLD (diagnostic odds ratio 12.33, 95% confidence interval: 11.16–13.63). DISCUSSION: An ECG-enabled ML model affords great promise in identifying advanced CLD in low resource areas.Keywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism (U01AA026886)
- National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK007066)
This publication has 14 references indexed in Scilit:
- Global burden of liver disease: 2023 updateJournal of Hepatology, 2023
- Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the PopulationClinical Gastroenterology and Hepatology, 2022
- Time to focus on chronic liver diseases in the community: A review of primary care hepatology tools, pathways of care and reimbursement mechanismsJournal of Hepatology, 2022
- The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortalityThe Lancet, 2022
- Liver cirrhosisThe Lancet, 2021
- Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesHepatology, 2021
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 updateJournal of Hepatology, 2021
- Contemporary Epidemiology of Chronic Liver Disease and CirrhosisClinical Gastroenterology and Hepatology, 2020
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Gastroenterology & Hepatology, 2020
- Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogramNature Medicine, 2019